BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32127912)

  • 1. IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells.
    Dong C; Zhang J; Fang S; Liu F
    Cell Div; 2020; 15():4. PubMed ID: 32127912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.
    Lin W; Niu R; Park SM; Zou Y; Kim SS; Xia X; Xing S; Yang Q; Sun X; Yuan Z; Zhou S; Zhang D; Kwon HJ; Park S; Il Kim C; Koo H; Liu Y; Wu H; Zheng M; Yoo H; Shi B; Park JB; Yin J
    Nat Commun; 2023 Mar; 14(1):1578. PubMed ID: 36949068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP5, as a Prognostic Indicator Promotes Tumor Progression and Correlates with Immune Microenvironment in Glioma.
    Lin J; Huang G; Zeng Q; Zhang R; Lin Y; Li Y; Huang B; Pan H
    J Cancer; 2024; 15(1):232-250. PubMed ID: 38164271
    [No Abstract]   [Full Text] [Related]  

  • 4. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.
    Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H
    Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway.
    Geng Y; Xu C; Wang Y; Zhang L
    Onco Targets Ther; 2020; 13():5721-5729. PubMed ID: 32606784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BYSL Promotes Glioblastoma Cell Migration, Invasion, and Mesenchymal Transition Through the GSK-3β/β-Catenin Signaling Pathway.
    Sha Z; Zhou J; Wu Y; Zhang T; Li C; Meng Q; Musunuru PP; You F; Wu Y; Yu R; Gao S
    Front Oncol; 2020; 10():565225. PubMed ID: 33178594
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromobox 7/8 serve as independent indicators for glioblastoma
    Zheng ZQ; Yuan GQ; Kang NL; Nie QQ; Zhang GG; Wang Z
    Front Neurol; 2022; 13():912039. PubMed ID: 36034290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
    Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
    Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
    Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC
    Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
    Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
    Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells.
    Wang J; Ding N; Li Y; Cheng H; Wang D; Yang Q; Deng Y; Yang Y; Li Y; Ruan X; Xie F; Zhao H; Fang X
    Oncotarget; 2015 Aug; 6(24):20636-49. PubMed ID: 26010068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
    Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
    Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
    [No Abstract]   [Full Text] [Related]  

  • 15. Decorin Suppresses Invasion and EMT Phenotype of Glioma by Inducing Autophagy
    Jia Y; Feng Q; Tang B; Luo X; Yang Q; Yang H; Li Q
    Front Oncol; 2021; 11():659353. PubMed ID: 34386415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.
    Liu B; Liu Y; Jiang Y
    Oncol Rep; 2015 May; 33(5):2583-91. PubMed ID: 25708368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.
    Qiu XY; Hu DX; Chen WQ; Chen RQ; Qian SR; Li CY; Li YJ; Xiong XX; Liu D; Pan F; Yu SB; Chen XQ
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1754-1769. PubMed ID: 29510196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
    Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
    J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.